PredictAYA

🎬Get to know PredictAYA Work Package 7-Communication, dissemination, stakeholder engagement, policy, and European initiative clustering

We will engage with key stakeholder groups and other EU initiatives, and develop new #oncofertility guidelines for young cancer survivors. Lead: @nkinl.bsky.social

🎬In today's series "Inside PredictAYA Work Packages (WPs)": WP6-Postcancer reproductive health, sexuality and quality of life
WP6 aims to understand how #cancer and its treatments affect #pregnancy outcomes, #sexualhealth and #qualityoflife of young survivors. Lead: @ulbruxelles.bsky.social

🌍 Today is #WorldCancerDay

The theme #UnitedbyUnique reminds us that every #cancer journey is different. People-centredness is essential in #oncofertility care for adolescents and young adults (AYAs). PredictAYA contributes by delivering patient-centred solutions in oncofertility care for AYAs.

🎬In today's series "Inside PredictAYA Work Packages (WPs)": WP5-Late effect of cancer therapies on fertility and reproduction in males
WP5 aims to understand how #cancer and its treatments affect #fertility in young men to support personalised #oncofertility counselling. Lead: University of Florence

🎬In today's series "Inside PredictAYA Work Packages (WPs)": WP4-Clinical research on ovarian toxicity from large cohorts across Europe
WP4 aims to understand how #cancer and its treatments affect #fertility in young women to support personalised #oncofertility counselling. Lead: @unibe.ch #HorizonEU

🌟 Help shape life after testicular cancer

TRANSCEND-XR is hosting World Café sessions - small, interactive online conversations where survivors and loved ones can share what life after treatment feels like.

Your insights will help shape a new XR educational intervention for survivorship. 💬

🎬 In today's series "Inside PredictAYA Work Packages (WPs)": WP3 - Pharmacogenetic modelling

WP3 aims to understand how cancer treatments affect fertility and long-term health in young people using innovative methods.

Lead: @liu.se

#HorizonEU #CancerResearch #AYAOncology #Pharmacogenetics

🎬 In today's series "Inside PredictAYA Work Packages (WPs)": WP2 - Epidemiology of late effects on European cohorts

WP2 examines how cancer and its treatment affect the long-term health of adolescents and young adults (AYAs) across Europe.

Lead: @ki.se i.se

#HorizonEU #CancerResearch #AYA

✨ We're starting the new year with our weekly series "Inside PredictAYA Work Packages (WPs)", taking a closer look at the components and activities of the PredictAYA project.

🎬 First: WP1 - Project Management and Coordination, Data Management, IPR and Ethics

Lead: @ki.se

✨ Best wishes for a happy new year from the PredictAYA team!

2025 marked the beginning of our journey, and we’re grateful to everyone who’s been part of these first steps.

Wishing you a wonderful, healthy, and successful 2026!

📣 Are you a young #cancersurvivor (diagnosed aged 15-39) or a relative of someone who is? Do you want to help shape the future of care for young survivors? Join our Patient & Relatives Advisory Board! #PatientEngagement #HorizonEU #CancerResearch
👉https://predictaya.eu/call-for-interest-prab/

✨Our project website is now live! Visit us at predictaya.eu and learn about our mission and approach, project partners, synergy project, news and upcoming events.
#HorizonEU #MissionCancer
@ki.se @nkinl.bsky.social

🌟 Partner spotlight: Inselspital Bern.

The University hospital Bern is one of Switzerland’s leading hospitals. The University Women’s hospital also focuses on research in gonadal toxicity and fertility preservation in cancer disease. In PredictAYA, Bern leads clinical research on ovarian toxicity.

🌟 Partner spotlight: Linköping University @liu.se

LiU advances world-leading, translational research environments. In PredictAYA, LiU contributes to finding predictors of reproductive organ and late toxicity of cancer by working on genetic prediction models and supporting epidemiological studies.

🌟 Partner spotlight: @inserm.fr, @chuangers.bsky.social,
@chulille.bsky.social, @hospicescivilslyon.bsky.social and Centre Leon Berard. The French research and oncology centres contribute to PredictAYA with collection and analysis of data from adolescent and young adult cancer survivors. #HorizonEU

🌟 Partner spotlight: Karolinska University Hospital, @regionstockholm.bsky.social
Karolinska University Hospital ranks among the world's best hospitals. Its clinical program for fertility preservation is the largest in Sweden. In PredictAYA, the hospital provides clinical data and patient inclusion.

🌟 Partner spotlight: @uniheidelberg.bsky.social
The Department of Gynecological Endocrinology and Fertility Disorders at the University of Heidelberg is a leading REI center in Germany. In PredictAYA, it leads communication and stakeholder engagement in Germany for patient recruitment and follow-up.

🌟 Partner spotlight: Civitta Foundation
Civitta is specialised in delivering European projects across diverse sectors. In PredictAYA, the team supports project management and coordination, particularly regarding ethical guidance and data management planning.
#HorizonEU

🌟 Partner spotlight: European Cancer Organisation (ECO), @europeancancer.bsky.social
ECO is a not-for-profit federation of member organisations working in cancer at European level. In PredictAYA, ECO leads stakeholder engagement and policy activities.
#HorizonEU

🌟 Partner spotlight: Université Libre de Bruxelles -
@ulbruxelles.bsky.social
The PredictAYA team at the Research Laboratory on Human Reproduction leads Work Package 6 on reproductive health, sexuality and quality of life after cancer.
#HorizonEU

🌟 Partner spotlight: University of Tartu
The PredictAYA team at the Institute of Clinical Medicine and the Institute of Genomics co-leads Work Package 3 with a focus on developing prediction models for late toxicity or long-term effects of cancer treatment.
#HorizonEU

🌟 Partner spotlight: The University of Florence
In #PredictAYA, Csilla Krausz' team at the Andrology Unit leads research activities to understand and predict late effects of cancer therapies on fertility and testicular function in male adolescent and young adult (AYA) cancer survivors.
#HorizonEU

🌟 Partner spotlight: Netherlands Cancer Institute @nkinl.bsky.social. In #PredictAYA, the research group on personalised oncology in adolescents and young adults leads communication, dissemination and stakeholder engagement and supports studies on late effect of cancer treatment on European cohorts.

🌟 Partner spotlight: Ospedale Policlinico San Martino. In #PredictAYA, the team (@cmassarottimd.bsky.social) co-leads the work on gynecological follow-up after cancer therapies and provides data to analyse late effect of cancer therapies on fertility and reproductive health. #HorizonEU

🌟 Partner spotlight: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano. In #PredictAYA, the oncology institute contributes to epidemiological studies of late effects of cancer treatments thanks to the EUROCARE project it leads, as well as research on #fertilitypreservation in AYAs. #HorizonEU

🌟 Partner spotlight: Medical University Innsbruck @i-med.ac.at
The Department of Gynecological Endocrinology & Reproductive Medicine is a leader in #fertilitypreservation & #reproductivehealth. In #PredictAYA, it contributes to clinical data collection across project work packages. #HorizonEU

👋Meet the team in Leeds working on PredictAYA: Adam Glaser, Richard Feltbower - @rgfeltbower.bsky.social, Nicola Hughes, Dan Stark, Helen Picton, Richard Cubbons, and Rebecca Mottram.